Class I — Most Severe

Silvestri Sweets Recalls Holiday Bark for Undeclared Allergens

FreshRecall Team Silvestri Sweet, Inc. Undeclared Allergen

This recall was posted 3 months ago. Check the FDA source for the latest status.

Class I Recall — Most Serious

This is a Class I recall — the most serious type. Products covered by this recall may cause serious health consequences or death.

Front label panel of Choceur Cookie Butter Holiday Bark in 5 oz. bags. Back label panel of Choceur Cookie Butter Holiday Bark in 5 oz. bags. Front label panel of Choceur Pecan Cranberry & Cinnamon Holiday Bark in 5 oz. bags Back label panel of Choceur Pecan Cranberry & Cinnamon Holiday bark in 5 oz. bags

Silvestri Sweets Inc. has issued a voluntary recall of its 5-ounce Choceur branded Holiday Barks due to undeclared allergens. This recall affects two products: Cookie Butter Holiday Bark and Pecan, Cranberry & Cinnamon Holiday Bark.

Products Affected:

  • Choceur Cookie Butter Holiday Bark: Lot #28525, #29925, #30625 with Best By dates in 05/2026 and 06/2026.
  • Choceur Pecan, Cranberry & Cinnamon Holiday Bark: Lot #28525, #29925, #30625 with Best By dates in 08/2026 and 09/2026.

Reason for Recall:

The Cookie Butter Holiday Bark may contain undeclared pecans, and the Pecan, Cranberry & Cinnamon Holiday Bark may contain undeclared wheat. These allergens pose a risk of serious or life-threatening allergic reactions for individuals with pecan or wheat allergies.

Consumer Guidance:

Consumers who have purchased these products are advised to discard them immediately. For more information, they can contact Silvestri Sweets at 1-630-232-2500, Monday through Friday, 8:30 am to 4:30 pm CST, or email [email protected].

Health Risks:

No illnesses have been reported in connection with this recall. The issue was identified after a packaging error was discovered, potentially due to a temporary breakdown in production processes.

Where Products Were Sold

This recall affects products distributed nationwide across the United States.

Tags

View original FDA announcement